CSBR:NASDAQ
Champions Oncology Inc
4,70 US$
0,00%
(0,00) 1D
13 ნოე, 15:57:39 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Mkt. cap
65,49 მლნ.
Avg. vol.
8,15 ათ.
Volume
249,00
52-wk high
8,31 US$
52-wk low
4,52 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
Mkt. cap
65,49 მლნ.
Avg. vol.
8,15 ათ.
Volume
249,00
52-wk high
8,31 US$
52-wk low
4,52 US$
EPS
-0,08 US$
Beta
0,47
Shares outstanding
13,92 მლნ.
No. of employees
217
News stories
From web sources and news partners
The Korea Times
·
45 წუთის წინ
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
ChartMill
·
1 საათის წინ
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
TradingView
·
1 საათის წინ
Forget Nvidia—Wall Street Sees S&P 500 at 8,900, Putting These ETFs in Play
Stocktwits
·
1 საათის წინ
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ნიუ-ჯერსი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitechampionsoncology.com